Skip to main content
Erschienen in: Neurocritical Care 2/2017

19.12.2016 | Review Article

Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage

verfasst von: Erik G. Hayman, Aaron Wessell, Volodymyr Gerzanich, Kevin N. Sheth, J. Marc Simard

Erschienen in: Neurocritical Care | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

A growing body of clinical literature emphasizes the impact of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (aSAH). Aneurysm rupture itself initiates global cerebral edema in up to two thirds of cases. Although cerebral edema is not a universal feature of aSAH, it portends a poor clinical course, with quantitative analysis revealing a direct correlation between cerebral edema and poor outcome, including mortality and cognitive deficits. Mechanistically, global cerebral edema has been linked to global ischemia at the time of aneurysm rupture, dysfunction of autoregulation, blood breakdown products, neuroinflammation, and hyponatremia/endocrine abnormalities. At a molecular level, several culprits have been identified, including aquaporin-4, matrix metalloproteinase-9, SUR1-TRPM4 cation channels, vascular endothelial growth factor, bradykinin, and others. Here, we review these cellular and molecular mechanisms of global cerebral edema formation in aSAH. Given the importance of edema to the outcome of patients with aSAH and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease.
Literatur
2.
Zurück zum Zitat Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–68.CrossRefPubMedPubMedCentral Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–68.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab. 2016;36:513–38.CrossRefPubMed Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab. 2016;36:513–38.CrossRefPubMed
4.
Zurück zum Zitat Rieth KG, Fujiwara K, Di Chiro G, et al. Serial measurements of CT attenuation and specific gravity in experimental cerebral edema. Radiology. 1980;135:343–8.CrossRefPubMed Rieth KG, Fujiwara K, Di Chiro G, et al. Serial measurements of CT attenuation and specific gravity in experimental cerebral edema. Radiology. 1980;135:343–8.CrossRefPubMed
5.
Zurück zum Zitat Na DG, Kim EY, Ryoo JW, et al. CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion-and perfusion-weighted MR imaging. Radiology. 2005;235:992–8.CrossRefPubMed Na DG, Kim EY, Ryoo JW, et al. CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion-and perfusion-weighted MR imaging. Radiology. 2005;235:992–8.CrossRefPubMed
6.
Zurück zum Zitat Ivanidze J, Kallas ON, Gupta A, et al. Application of blood–brain barrier permeability imaging in global cerebral edema. AJNR Am J Neuroradiol. 2016;37:1599–603.CrossRefPubMedPubMedCentral Ivanidze J, Kallas ON, Gupta A, et al. Application of blood–brain barrier permeability imaging in global cerebral edema. AJNR Am J Neuroradiol. 2016;37:1599–603.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. part 1: overall management results. J Neurosurg. 1990;73:18–36.CrossRefPubMed Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. part 1: overall management results. J Neurosurg. 1990;73:18–36.CrossRefPubMed
9.
Zurück zum Zitat Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225–32.CrossRefPubMed Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225–32.CrossRefPubMed
10.
Zurück zum Zitat Zetterling M, Hallberg L, Ronne-Engstrom E. Early global brain oedema in relation to clinical admission parameters and outcome in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2010;152:1527–33 (discussion 33).CrossRef Zetterling M, Hallberg L, Ronne-Engstrom E. Early global brain oedema in relation to clinical admission parameters and outcome in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2010;152:1527–33 (discussion 33).CrossRef
11.
Zurück zum Zitat Inamasu J, Nakatsukasa M, Hayashi T, Kato Y, Hirose Y. Early CT signs of hypoxia in patients with subarachnoid hemorrhage presenting with cardiac arrest: early CT signs in SAH patients presenting with CA. Acta Neurochir Suppl. 2013;118:181–4.PubMed Inamasu J, Nakatsukasa M, Hayashi T, Kato Y, Hirose Y. Early CT signs of hypoxia in patients with subarachnoid hemorrhage presenting with cardiac arrest: early CT signs in SAH patients presenting with CA. Acta Neurochir Suppl. 2013;118:181–4.PubMed
12.
Zurück zum Zitat Liu Y, Soppi V, Mustonen T, et al. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment. Radiology. 2007;242:518–25.CrossRefPubMed Liu Y, Soppi V, Mustonen T, et al. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment. Radiology. 2007;242:518–25.CrossRefPubMed
13.
Zurück zum Zitat Beseoglu K, Holtkamp K, Steiger HJ, Hanggi D. Fatal aneurysmal subarachnoid haemorrhage: causes of 30-day in-hospital case fatalities in a large single-centre historical patient cohort. Clin Neurol Neurosurg. 2013;115:77–81.CrossRefPubMed Beseoglu K, Holtkamp K, Steiger HJ, Hanggi D. Fatal aneurysmal subarachnoid haemorrhage: causes of 30-day in-hospital case fatalities in a large single-centre historical patient cohort. Clin Neurol Neurosurg. 2013;115:77–81.CrossRefPubMed
14.
Zurück zum Zitat Lagares A, Gomez PA, Lobato RD, Alen JF, Alday R, Campollo J. Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien). 2001;143:665–72.CrossRef Lagares A, Gomez PA, Lobato RD, Alen JF, Alday R, Campollo J. Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien). 2001;143:665–72.CrossRef
15.
Zurück zum Zitat Choi HA, Bajgur SS, Jones WH, et al. Quantification of cerebral edema after subarachnoid hemorrhage. Neurocrit Care. 2016;25:64–70.CrossRefPubMed Choi HA, Bajgur SS, Jones WH, et al. Quantification of cerebral edema after subarachnoid hemorrhage. Neurocrit Care. 2016;25:64–70.CrossRefPubMed
16.
Zurück zum Zitat Kreiter KT, Copeland D, Bernardini GL, et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke. 2002;33:200–8.CrossRefPubMed Kreiter KT, Copeland D, Bernardini GL, et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke. 2002;33:200–8.CrossRefPubMed
17.
Zurück zum Zitat Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998;29:2155–61.CrossRefPubMed Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998;29:2155–61.CrossRefPubMed
18.
Zurück zum Zitat Jadhav V, Sugawara T, Zhang J, Jacobson P, Obenaus A. Magnetic resonance imaging detects and predicts early brain injury after subarachnoid hemorrhage in a canine experimental model. J Neurotrauma. 2008;25:1099–106.CrossRefPubMedPubMedCentral Jadhav V, Sugawara T, Zhang J, Jacobson P, Obenaus A. Magnetic resonance imaging detects and predicts early brain injury after subarachnoid hemorrhage in a canine experimental model. J Neurotrauma. 2008;25:1099–106.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Thal SC, Sporer S, Klopotowski M, et al. Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. Lab Investig J Neurosurg. 2009;111:988–94.CrossRef Thal SC, Sporer S, Klopotowski M, et al. Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. Lab Investig J Neurosurg. 2009;111:988–94.CrossRef
20.
Zurück zum Zitat Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervos-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 1982;13:368–79.CrossRefPubMed Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervos-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 1982;13:368–79.CrossRefPubMed
21.
Zurück zum Zitat Handa Y, Takeuchi H, Kabuto M, et al. Blood–brain barrier disruption caused by impairment of cerebral autoregulation during chronic cerebral vasospasm in primates. Acta Neurochir Suppl (Wien). 1990;51:338–40. Handa Y, Takeuchi H, Kabuto M, et al. Blood–brain barrier disruption caused by impairment of cerebral autoregulation during chronic cerebral vasospasm in primates. Acta Neurochir Suppl (Wien). 1990;51:338–40.
22.
Zurück zum Zitat Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988;22:654–61.CrossRefPubMed Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988;22:654–61.CrossRefPubMed
23.
Zurück zum Zitat Kamiya K, Kuyama H, Symon L. An experimental study of the acute stage of subarachnoid hemorrhage. J Neurosurg. 1983;59:917–24.CrossRefPubMed Kamiya K, Kuyama H, Symon L. An experimental study of the acute stage of subarachnoid hemorrhage. J Neurosurg. 1983;59:917–24.CrossRefPubMed
24.
Zurück zum Zitat Simard JM, Chen M, Tarasov KV, et al. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433–40.CrossRefPubMedPubMedCentral Simard JM, Chen M, Tarasov KV, et al. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433–40.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Baradaran H, Fodera V, Mir D, et al. Evaluating CT perfusion deficits in global cerebral edema after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2015;36:1431–5.CrossRefPubMedPubMedCentral Baradaran H, Fodera V, Mir D, et al. Evaluating CT perfusion deficits in global cerebral edema after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2015;36:1431–5.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Westermaier T, Stetter C, Raslan F, Vince GH, Ernestus RI. Brain edema formation correlates with perfusion deficit during the first six hours after experimental subarachnoid hemorrhage in rats. Exp Transl Stroke Med. 2012;4:8.CrossRefPubMedPubMedCentral Westermaier T, Stetter C, Raslan F, Vince GH, Ernestus RI. Brain edema formation correlates with perfusion deficit during the first six hours after experimental subarachnoid hemorrhage in rats. Exp Transl Stroke Med. 2012;4:8.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Terpolilli NA, Feiler S, Dienel A, et al. Nitric oxide inhalation reduces brain damage, prevents mortality, and improves neurological outcome after subarachnoid hemorrhage by resolving early pial microvasospasms. J Cereb Blood Flow Metab. 2016;36:2096–107. doi:10.1177/0271678X15605848. Terpolilli NA, Feiler S, Dienel A, et al. Nitric oxide inhalation reduces brain damage, prevents mortality, and improves neurological outcome after subarachnoid hemorrhage by resolving early pial microvasospasms. J Cereb Blood Flow Metab. 2016;36:2096–107. doi:10.​1177/​0271678X15605848​.
28.
Zurück zum Zitat Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230–6.CrossRefPubMed Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230–6.CrossRefPubMed
29.
Zurück zum Zitat Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol. 2002;135:823–9.CrossRefPubMedPubMedCentral Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol. 2002;135:823–9.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg. 1985;62:59–67.CrossRefPubMed Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg. 1985;62:59–67.CrossRefPubMed
31.
Zurück zum Zitat Tran Dinh YR, Lot G, Benrabah R, Baroudy O, Cophignon J, Seylaz J. Abnormal cerebral vasodilation in aneurysmal subarachnoid hemorrhage: use of serial 133Xe cerebral blood flow measurement plus acetazolamide to assess cerebral vasospasm. J Neurosurg. 1993;79:490–3.CrossRefPubMed Tran Dinh YR, Lot G, Benrabah R, Baroudy O, Cophignon J, Seylaz J. Abnormal cerebral vasodilation in aneurysmal subarachnoid hemorrhage: use of serial 133Xe cerebral blood flow measurement plus acetazolamide to assess cerebral vasospasm. J Neurosurg. 1993;79:490–3.CrossRefPubMed
32.
Zurück zum Zitat Muhammad S, Guresir A, Greschus S, Scorzin J, Vatter H, Guresir E. posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke. 2016;47:519–22.CrossRefPubMed Muhammad S, Guresir A, Greschus S, Scorzin J, Vatter H, Guresir E. posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke. 2016;47:519–22.CrossRefPubMed
33.
Zurück zum Zitat Yin W, Tibbs R, Tang J, Badr A, Zhang J. Haemoglobin and ATP levels in CSF from a dog model of vasospasm. J Clin Neurosci. 2002;9:425–8.CrossRefPubMed Yin W, Tibbs R, Tang J, Badr A, Zhang J. Haemoglobin and ATP levels in CSF from a dog model of vasospasm. J Clin Neurosci. 2002;9:425–8.CrossRefPubMed
34.
Zurück zum Zitat Suzuki M, Kudo A, Otawara Y, Hirashima Y, Takaku A, Ogawa A. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery. 1999;44:487–93 (discussion 93-4).CrossRefPubMed Suzuki M, Kudo A, Otawara Y, Hirashima Y, Takaku A, Ogawa A. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery. 1999;44:487–93 (discussion 93-4).CrossRefPubMed
35.
Zurück zum Zitat Kwon MS, Woo SK, Kurland DB, et al. Methemoglobin is an endogenous toll-like receptor 4 ligand-relevance to subarachnoid hemorrhage. Int J Mol Sci. 2015;16:5028–46.CrossRefPubMedPubMedCentral Kwon MS, Woo SK, Kurland DB, et al. Methemoglobin is an endogenous toll-like receptor 4 ligand-relevance to subarachnoid hemorrhage. Int J Mol Sci. 2015;16:5028–46.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96:287–93.CrossRefPubMed Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96:287–93.CrossRefPubMed
37.
Zurück zum Zitat Sugawara T, Jadhav V, Ayer R, Chen W, Suzuki H, Zhang JH. Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats. Stroke. 2009;40:1530–2.CrossRefPubMedPubMedCentral Sugawara T, Jadhav V, Ayer R, Chen W, Suzuki H, Zhang JH. Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats. Stroke. 2009;40:1530–2.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Xu T, Zhang WG, Sun J, et al. Protective effects of thrombomodulin on microvascular permeability after subarachnoid hemorrhage in mouse model. Neuroscience. 2015;299:18–27.CrossRefPubMed Xu T, Zhang WG, Sun J, et al. Protective effects of thrombomodulin on microvascular permeability after subarachnoid hemorrhage in mouse model. Neuroscience. 2015;299:18–27.CrossRefPubMed
39.
Zurück zum Zitat Yu ZQ, Jia Y, Chen G. Possible involvement of cathepsin B/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats. Neuropathol Appl Neurobiol. 2014;40:270–83.CrossRefPubMed Yu ZQ, Jia Y, Chen G. Possible involvement of cathepsin B/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats. Neuropathol Appl Neurobiol. 2014;40:270–83.CrossRefPubMed
40.
Zurück zum Zitat Siler DA, Berlow YA, Kukino A, et al. Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage. Stroke. 2015;46:1916–22.CrossRefPubMedPubMedCentral Siler DA, Berlow YA, Kukino A, et al. Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage. Stroke. 2015;46:1916–22.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat You W, Wang Z, Li H, et al. Inhibition of mammalian target of rapamycin attenuates early brain injury through modulating microglial polarization after experimental subarachnoid hemorrhage in rats. J Neurol Sci. 2016;367:224–31.CrossRefPubMed You W, Wang Z, Li H, et al. Inhibition of mammalian target of rapamycin attenuates early brain injury through modulating microglial polarization after experimental subarachnoid hemorrhage in rats. J Neurol Sci. 2016;367:224–31.CrossRefPubMed
42.
Zurück zum Zitat Simard JM, Geng Z, Woo SK, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:317–30.CrossRefPubMed Simard JM, Geng Z, Woo SK, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:317–30.CrossRefPubMed
43.
Zurück zum Zitat Sozen T, Tsuchiyama R, Hasegawa Y, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2009;40:2519–25.CrossRefPubMedPubMedCentral Sozen T, Tsuchiyama R, Hasegawa Y, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2009;40:2519–25.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Sherlock M, O’Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2006;64:250–4.CrossRef Sherlock M, O’Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2006;64:250–4.CrossRef
45.
Zurück zum Zitat Cuesta M, Hannon MJ, Thompson CJ. Diagnosis and treatment of hyponatraemia in neurosurgical patients. Endocrinol Nutr. 2016;63:230–8.CrossRefPubMed Cuesta M, Hannon MJ, Thompson CJ. Diagnosis and treatment of hyponatraemia in neurosurgical patients. Endocrinol Nutr. 2016;63:230–8.CrossRefPubMed
46.
Zurück zum Zitat Zeynalov E, Jones SM, Seo JW, Snell LD, Elliott JP. Arginine-vasopressin receptor blocker conivaptan reduces brain edema and blood–brain barrier disruption after experimental stroke in mice. PLoS ONE. 2015;10:e0136121.CrossRefPubMedPubMedCentral Zeynalov E, Jones SM, Seo JW, Snell LD, Elliott JP. Arginine-vasopressin receptor blocker conivaptan reduces brain edema and blood–brain barrier disruption after experimental stroke in mice. PLoS ONE. 2015;10:e0136121.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Nakayama S, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A. Conivaptan, a selective arginine vasopressin v1a and v2 receptor antagonist attenuates global cerebral edema following experimental cardiac arrest via perivascular pool of aquaporin-4. Neurocrit Care. 2016;24:273–82.CrossRefPubMed Nakayama S, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A. Conivaptan, a selective arginine vasopressin v1a and v2 receptor antagonist attenuates global cerebral edema following experimental cardiac arrest via perivascular pool of aquaporin-4. Neurocrit Care. 2016;24:273–82.CrossRefPubMed
48.
Zurück zum Zitat Doczi T, Laszlo FA, Szerdahelyi P, Joo F. Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery. 1984;14:436–41.CrossRefPubMed Doczi T, Laszlo FA, Szerdahelyi P, Joo F. Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery. 1984;14:436–41.CrossRefPubMed
49.
Zurück zum Zitat Laszlo FA, Varga C, Doczi T. Cerebral oedema after subarachnoid haemorrhage. pathogenetic significance of vasopressin. Acta Neurochir (Wien). 1995;133:122–33.CrossRef Laszlo FA, Varga C, Doczi T. Cerebral oedema after subarachnoid haemorrhage. pathogenetic significance of vasopressin. Acta Neurochir (Wien). 1995;133:122–33.CrossRef
50.
Zurück zum Zitat Hockel K, Scholler K, Trabold R, Nussberger J, Plesnila N. Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke. 2012;43:227–32.CrossRefPubMed Hockel K, Scholler K, Trabold R, Nussberger J, Plesnila N. Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke. 2012;43:227–32.CrossRefPubMed
51.
Zurück zum Zitat Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007;6:3–10.CrossRefPubMed Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007;6:3–10.CrossRefPubMed
53.
Zurück zum Zitat Wang D, Nykanen M, Yang N, et al. Altered cellular localization of aquaporin-1 in experimental hydrocephalus in mice and reduced ventriculomegaly in aquaporin-1 deficiency. Mol Cell Neurosci. 2011;46:318–24.CrossRefPubMed Wang D, Nykanen M, Yang N, et al. Altered cellular localization of aquaporin-1 in experimental hydrocephalus in mice and reduced ventriculomegaly in aquaporin-1 deficiency. Mol Cell Neurosci. 2011;46:318–24.CrossRefPubMed
54.
Zurück zum Zitat Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–63.CrossRefPubMed Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–63.CrossRefPubMed
55.
Zurück zum Zitat Yan JH, Khatibi NH, Han HB, et al. p53-induced uncoupling expression of aquaporin-4 and inwardly rectifying K+4.1 channels in cytotoxic edema after subarachnoid hemorrhage. CNS Neurosci Ther. 2012;18:334–42.CrossRefPubMed Yan JH, Khatibi NH, Han HB, et al. p53-induced uncoupling expression of aquaporin-4 and inwardly rectifying K+4.1 channels in cytotoxic edema after subarachnoid hemorrhage. CNS Neurosci Ther. 2012;18:334–42.CrossRefPubMed
56.
Zurück zum Zitat Badaut J, Brunet JF, Grollimund L, et al. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl. 2003;86:495–8.PubMed Badaut J, Brunet JF, Grollimund L, et al. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl. 2003;86:495–8.PubMed
57.
Zurück zum Zitat Tait MJ, Saadoun S, Bell BA, Verkman AS, Papadopoulos MC. Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage. Neuroscience. 2010;167:60–7.CrossRefPubMedPubMedCentral Tait MJ, Saadoun S, Bell BA, Verkman AS, Papadopoulos MC. Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage. Neuroscience. 2010;167:60–7.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Wang Z, Meng CJ, Shen XM, et al. Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood–brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci. 2012;48:273–80.CrossRefPubMed Wang Z, Meng CJ, Shen XM, et al. Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood–brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci. 2012;48:273–80.CrossRefPubMed
59.
Zurück zum Zitat Chou SH, Feske SK, Simmons SL, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2:600–7.CrossRefPubMedPubMedCentral Chou SH, Feske SK, Simmons SL, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2:600–7.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Horstmann S, Su Y, Koziol J, Meyding-Lamade U, Nagel S, Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci. 2006;251:82–6.CrossRefPubMed Horstmann S, Su Y, Koziol J, Meyding-Lamade U, Nagel S, Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci. 2006;251:82–6.CrossRefPubMed
61.
Zurück zum Zitat Chou SH, Lee PS, Konigsberg RG, et al. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke. 2011;42:3624–7.CrossRefPubMedPubMedCentral Chou SH, Lee PS, Konigsberg RG, et al. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke. 2011;42:3624–7.CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Egashira Y, Zhao H, Hua Y, Keep RF, Xi G. White matter injury after subarachnoid hemorrhage: role of blood–brain barrier disruption and matrix metalloproteinase-9. Stroke. 2015;46:2909–15.CrossRefPubMedPubMedCentral Egashira Y, Zhao H, Hua Y, Keep RF, Xi G. White matter injury after subarachnoid hemorrhage: role of blood–brain barrier disruption and matrix metalloproteinase-9. Stroke. 2015;46:2909–15.CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Feiler S, Plesnila N, Thal SC, Zausinger S, Scholler K. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis. 2011;32:289–95.CrossRefPubMed Feiler S, Plesnila N, Thal SC, Zausinger S, Scholler K. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis. 2011;32:289–95.CrossRefPubMed
64.
Zurück zum Zitat Sherchan P, Lekic T, Suzuki H, et al. Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats. J Neurotrauma. 2011;28:2503–12.CrossRefPubMedPubMedCentral Sherchan P, Lekic T, Suzuki H, et al. Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats. J Neurotrauma. 2011;28:2503–12.CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Guo Z, Sun X, He Z, Jiang Y, Zhang X, Zhang JH. Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage. Neurol Res. 2010;32:715–20.CrossRefPubMed Guo Z, Sun X, He Z, Jiang Y, Zhang X, Zhang JH. Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage. Neurol Res. 2010;32:715–20.CrossRefPubMed
66.
Zurück zum Zitat Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab. 2012;32:1699–717.CrossRefPubMedPubMedCentral Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab. 2012;32:1699–717.CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Kimberly WT, Battey TW, Pham L, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014;20:193–201.CrossRefPubMedPubMedCentral Kimberly WT, Battey TW, Pham L, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014;20:193–201.CrossRefPubMedPubMedCentral
68.
69.
Zurück zum Zitat Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15:1160–9.CrossRefPubMed Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15:1160–9.CrossRefPubMed
70.
Zurück zum Zitat Tosun C, Kurland DB, Mehta R, et al. Inhibition of the Sur1–Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke. 2013;44:3522–8.CrossRefPubMedPubMedCentral Tosun C, Kurland DB, Mehta R, et al. Inhibition of the Sur1–Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke. 2013;44:3522–8.CrossRefPubMedPubMedCentral
71.
Zurück zum Zitat Woo SK, Kwon MS, Geng Z, et al. Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8. J Cereb Blood Flow Metab. 2012;32:525–36.CrossRefPubMed Woo SK, Kwon MS, Geng Z, et al. Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8. J Cereb Blood Flow Metab. 2012;32:525–36.CrossRefPubMed
72.
Zurück zum Zitat Hou J, Kshettry VR, Selman WR, Bambakidis NC. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013;35:E2.CrossRefPubMed Hou J, Kshettry VR, Selman WR, Bambakidis NC. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013;35:E2.CrossRefPubMed
73.
Zurück zum Zitat Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108(Pt 6):2369–79.PubMed Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108(Pt 6):2369–79.PubMed
74.
Zurück zum Zitat Josko J, Gwozdz B, Hendryk S, Jedrzejowska-Szypulka H, Slowinski J, Jochem J. Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol. 2001;39:243–51.PubMed Josko J, Gwozdz B, Hendryk S, Jedrzejowska-Szypulka H, Slowinski J, Jochem J. Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol. 2001;39:243–51.PubMed
75.
Zurück zum Zitat Josko J. Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res. 2003;981:58–69.CrossRefPubMed Josko J. Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res. 2003;981:58–69.CrossRefPubMed
76.
Zurück zum Zitat Liu L, Fujimoto M, Kawakita F, et al. Anti-vascular endothelial growth factor treatment suppresses early brain injury after subarachnoid hemorrhage in mice. Mol Neurobiol. 2016;53:4529–38.CrossRefPubMed Liu L, Fujimoto M, Kawakita F, et al. Anti-vascular endothelial growth factor treatment suppresses early brain injury after subarachnoid hemorrhage in mice. Mol Neurobiol. 2016;53:4529–38.CrossRefPubMed
77.
Zurück zum Zitat Xu W, Xu R, Li X, Zhang H, Wang X, Zhu J. Downregulating hypoxia-inducible factor-1alpha expression with perfluorooctyl-bromide nanoparticles reduces early brain injury following experimental subarachnoid hemorrhage in rats. Am J Transl Res. 2016;8:2114–26.PubMedPubMedCentral Xu W, Xu R, Li X, Zhang H, Wang X, Zhu J. Downregulating hypoxia-inducible factor-1alpha expression with perfluorooctyl-bromide nanoparticles reduces early brain injury following experimental subarachnoid hemorrhage in rats. Am J Transl Res. 2016;8:2114–26.PubMedPubMedCentral
78.
Zurück zum Zitat Wu C, Hu Q, Chen J, et al. Inhibiting HIF-1alpha by 2ME2 ameliorates early brain injury after experimental subarachnoid hemorrhage in rats. Biochem Biophys Res Commun. 2013;437:469–74.CrossRefPubMed Wu C, Hu Q, Chen J, et al. Inhibiting HIF-1alpha by 2ME2 ameliorates early brain injury after experimental subarachnoid hemorrhage in rats. Biochem Biophys Res Commun. 2013;437:469–74.CrossRefPubMed
79.
Zurück zum Zitat Albert-Weissenberger C, Mencl S, Hopp S, Kleinschnitz C, Siren AL. Role of the kallikrein-kinin system in traumatic brain injury. Front Cell Neurosci. 2014;8:345.PubMedPubMedCentral Albert-Weissenberger C, Mencl S, Hopp S, Kleinschnitz C, Siren AL. Role of the kallikrein-kinin system in traumatic brain injury. Front Cell Neurosci. 2014;8:345.PubMedPubMedCentral
80.
Zurück zum Zitat Kasuya H, Shimizu T, Okada T, Takahashi K, Summerville T, Kitamura K. Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage. Acta Neurochir (Wien). 1988;91:120–5.CrossRef Kasuya H, Shimizu T, Okada T, Takahashi K, Summerville T, Kitamura K. Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage. Acta Neurochir (Wien). 1988;91:120–5.CrossRef
81.
Zurück zum Zitat Kunz M, Nussberger J, Holtmannspotter M, Bitterling H, Plesnila N, Zausinger S. Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure. J Neurotrauma. 2013;30:1638–44.CrossRefPubMed Kunz M, Nussberger J, Holtmannspotter M, Bitterling H, Plesnila N, Zausinger S. Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure. J Neurotrauma. 2013;30:1638–44.CrossRefPubMed
82.
Zurück zum Zitat Scholler K, Feiler S, Anetsberger S, Kim SW, Plesnila N. Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage. Neurosurgery. 2011;68:1118–23.CrossRefPubMed Scholler K, Feiler S, Anetsberger S, Kim SW, Plesnila N. Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage. Neurosurgery. 2011;68:1118–23.CrossRefPubMed
83.
Zurück zum Zitat Thal SC, Sporer S, Schmid-Elsaesser R, Plesnila N, Zausinger S. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome. Crit Care Med. 2009;37:2228–34.CrossRefPubMed Thal SC, Sporer S, Schmid-Elsaesser R, Plesnila N, Zausinger S. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome. Crit Care Med. 2009;37:2228–34.CrossRefPubMed
Metadaten
Titel
Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage
verfasst von
Erik G. Hayman
Aaron Wessell
Volodymyr Gerzanich
Kevin N. Sheth
J. Marc Simard
Publikationsdatum
19.12.2016
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 2/2017
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0354-7

Weitere Artikel der Ausgabe 2/2017

Neurocritical Care 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.